Cargando…

REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors

Despite G protein-coupled receptors (GPCRs) being important theapeutic targets, the signaling properties of many GPCRs remain poorly characterized. GPCR activation primarily initiates heterotrimeric G protein signaling. To detect ligand-induced G protein activation, Bioluminescence Resonance Energy...

Descripción completa

Detalles Bibliográficos
Autores principales: Boon, Katrijn, Vanalken, Nathan, Meyen, Eef, Schols, Dominique, Van Loy, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452170/
https://www.ncbi.nlm.nih.gov/pubmed/37622853
http://dx.doi.org/10.3390/bios13080767
_version_ 1785095602009276416
author Boon, Katrijn
Vanalken, Nathan
Meyen, Eef
Schols, Dominique
Van Loy, Tom
author_facet Boon, Katrijn
Vanalken, Nathan
Meyen, Eef
Schols, Dominique
Van Loy, Tom
author_sort Boon, Katrijn
collection PubMed
description Despite G protein-coupled receptors (GPCRs) being important theapeutic targets, the signaling properties of many GPCRs remain poorly characterized. GPCR activation primarily initiates heterotrimeric G protein signaling. To detect ligand-induced G protein activation, Bioluminescence Resonance Energy Transfer (BRET)-based biosensors were previously developed. Here, we designed a novel set of Nanoluciferase (NLuc) BRET-based biosensors (REGA-SIGN) that covers all Gα protein families (i.e., Gα(i/o), Gα(Ss/L), Gα(12/13) and Gα(q/15)). REGA-SIGN uses NLuc as a bioluminescent donor and LSS-mKATE2, a red-shifted fluorophore, as an acceptor. Due to the enhanced spectral separation between donor and acceptor emission and the availability of a stable substrate for NLuc, this donor–acceptor pair enables sensitive kinetic assessment of G protein activity. After optimization, the NLuc integration sites into the Gα subunit largely corresponded with previously reported integration sites, except for Gα(Ss/L) for which we describe an alternative NLuc insertion site. G protein rescue experiments validated the biological activity of these Gα donor proteins. Direct comparison between EGFP and LSS-mKATE2 as acceptor fluorophores revealed improved sensitivity for nearly all G protein subtypes when using the latter one. Hence, REGA-SIGN can be used as a panel of kinetic G protein biosensors with high sensitivity.
format Online
Article
Text
id pubmed-10452170
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104521702023-08-26 REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors Boon, Katrijn Vanalken, Nathan Meyen, Eef Schols, Dominique Van Loy, Tom Biosensors (Basel) Article Despite G protein-coupled receptors (GPCRs) being important theapeutic targets, the signaling properties of many GPCRs remain poorly characterized. GPCR activation primarily initiates heterotrimeric G protein signaling. To detect ligand-induced G protein activation, Bioluminescence Resonance Energy Transfer (BRET)-based biosensors were previously developed. Here, we designed a novel set of Nanoluciferase (NLuc) BRET-based biosensors (REGA-SIGN) that covers all Gα protein families (i.e., Gα(i/o), Gα(Ss/L), Gα(12/13) and Gα(q/15)). REGA-SIGN uses NLuc as a bioluminescent donor and LSS-mKATE2, a red-shifted fluorophore, as an acceptor. Due to the enhanced spectral separation between donor and acceptor emission and the availability of a stable substrate for NLuc, this donor–acceptor pair enables sensitive kinetic assessment of G protein activity. After optimization, the NLuc integration sites into the Gα subunit largely corresponded with previously reported integration sites, except for Gα(Ss/L) for which we describe an alternative NLuc insertion site. G protein rescue experiments validated the biological activity of these Gα donor proteins. Direct comparison between EGFP and LSS-mKATE2 as acceptor fluorophores revealed improved sensitivity for nearly all G protein subtypes when using the latter one. Hence, REGA-SIGN can be used as a panel of kinetic G protein biosensors with high sensitivity. MDPI 2023-07-28 /pmc/articles/PMC10452170/ /pubmed/37622853 http://dx.doi.org/10.3390/bios13080767 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boon, Katrijn
Vanalken, Nathan
Meyen, Eef
Schols, Dominique
Van Loy, Tom
REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
title REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
title_full REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
title_fullStr REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
title_full_unstemmed REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
title_short REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
title_sort rega-sign: development of a novel set of nanobret-based g protein biosensors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452170/
https://www.ncbi.nlm.nih.gov/pubmed/37622853
http://dx.doi.org/10.3390/bios13080767
work_keys_str_mv AT boonkatrijn regasigndevelopmentofanovelsetofnanobretbasedgproteinbiosensors
AT vanalkennathan regasigndevelopmentofanovelsetofnanobretbasedgproteinbiosensors
AT meyeneef regasigndevelopmentofanovelsetofnanobretbasedgproteinbiosensors
AT scholsdominique regasigndevelopmentofanovelsetofnanobretbasedgproteinbiosensors
AT vanloytom regasigndevelopmentofanovelsetofnanobretbasedgproteinbiosensors